NIOSH List of Hazardous Drugs in Healthcare Settings, 2024 | Publications | CDC
Summary: The 2024 NIOSH List of Hazardous Drugs in Healthcare Settings updates the 2016 guidance by adding 25 drugs, removing 7, and reorganizing the classification tables to improve safety protocols for healthcare workers.
The NIOSH List of Hazardous Drugs in Healthcare Settings, 2024 (DHHS Publication No. 2025-103) serves as an advisory resource for healthcare employers to identify drugs that pose potential occupational health risks. This edition supersedes the 2016 list, incorporating 25 new drugs and removing 7. The document outlines the criteria for defining hazardous drugs—including carcinogenicity, genotoxicity, and reproductive toxicity—and provides a methodology for facilities to develop their own site-specific hazardous drug lists. The 2024 update simplifies the presentation by reducing the number of tables to two and removing the separate category for developmental/reproductive hazards, while updating drug nomenclature and classification standards.
Document outline
1. Foreword 2. Acknowledgements 3. List of Acronyms 4. Drugs Considered Hazardous 5. Introduction 6. Defining Hazardous Drugs 7. Determining Whether a Drug Is Hazardous 8. Developing a Facility-specific List of Hazardous Drugs 9. References 10. NIOSH List of Hazardous Drugs in Healthcare Settings 2024 11. 2024 Hazardous Drugs List Changes 12. NIOSH List of Hazardous Drugs in Healthcare Settings, 2024, Table 1 13. NIOSH List of Hazardous Drugs in Healthcare Settings, 2024, Table 2 14. Changes to the Placement of Drugs From the 2016 List 15. Drugs Removed From the 2016 List 16. Drugs Moved to a Different Table